Oct 15, 2026 07:31AM
Oct 15, 2026 07:30AM
Oct 13, 2026 07:30AM
Oct 12, 2026 07:30AM
Oct 12, 2026 07:30AM
Sep 28, 2026 07:32AM
Sep 28, 2026 07:30AM U.S. Food and Drug Administration Awards Additional Funding for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations
Sep 17, 2026 08:32AM
Sep 17, 2026 08:32AM
Aug 5, 2026 07:30AM
Aug 4, 2026 07:30AM
Jul 30, 2026 07:30AM
Jul 28, 2026 07:30AM
Jul 23, 2026 05:00PM Pullback creates buying opportunity in this biotech stock: Oppenheimer
Jul 22, 2026 06:52AM
Jun 30, 2026 07:30AM
Jun 30, 2026 07:30AM
Jun 29, 2026 07:30AM
Jun 29, 2026 07:30AM
Jun 22, 2026 07:30AM
Jun 22, 2026 07:30AM FDA Grants Rolling Review of Palvella’s QTORIN™ Rapamycin NDA for Microcystic Lymphatic Malformations
Jun 9, 2026 08:43AM
Jun 9, 2026 08:43AM
Jun 3, 2026 07:30AM
Jun 3, 2026 07:30AM
Jun 2, 2026 07:30AM
May 27, 2026 07:31AM
May 27, 2026 07:30AM Palvella Therapeutics Strengthens QTORIN™ Pitavastatin Intellectual Property with Yale-Licensed U.S. Patent Providing Protection into 2043
May 21, 2026 07:30AM
May 20, 2026 04:30PM
May 20, 2026 04:30PM
May 15, 2026 07:30AM
May 15, 2026 07:30AM
May 15, 2026 07:30AM
May 13, 2026 07:30AM Palvella Therapeutics moves to NASDAQ Global Market
May 13, 2026 07:30AM
May 12, 2026 02:54AM
May 7, 2026 07:30AM
May 4, 2026 07:30AM
May 4, 2026 07:30AM
Apr 30, 2026 07:30AM
Apr 20, 2026 07:30AM Palvella to present QTORIN rapamycin study results at vascular congress
Apr 20, 2026 07:30AM
Apr 13, 2026 07:30AM
Apr 13, 2026 07:30AM
Apr 7, 2026 12:26PM
Apr 7, 2026 07:30AM
Mar 31, 2026 03:06PM
Mar 31, 2026 07:30AM Palvella Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update
Mar 30, 2026 07:31AM

334,267 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All